Sage Therapeutics Inc (NASDAQ: SAGE) Q2 2020 earnings call dated August 10, 2020 Corporate Participants: Jeff Boyle — Senior Director of Investor...
Novavax Inc (NASDAQ: NVAX) Q2 2020 earnings call dated Aug. 10, 2020 Corporate Participants: Silvia Taylor — Senior Vice President, Investor Relations...
Novavax (NASDAQ: NVAX) reported a loss of $17.5 million or $0.30 per share for the second quarter of 2020. Revenue...
Moderna Inc. (NASDAQ: MRNA) Q2 2020 earnings call dated Aug. 05, 2020 Corporate Participants: Lavina Talukdar — Head of Investor Relations Stephane...
Moderna, Inc., (Nasdaq: MRNA), a prime contender in Covid-19 vaccine research, on Wednesday, reported second-quarter financial results that smashed past...
Amarin (NASDAQ: AMRN) reported second quarter 2020 results yesterday. During the earnings conference call, the management and the analysts discussed...
Immunogen Inc (NASDAQ: IMGN) Q2 2020 earnings call dated July 31, 2020 Corporate Participants: Courtney O’Konek — Senior Director of Corporate Communications...
ImmunoGen Inc. (NASDAQ: IMGN) reported second quarter 2020 earnings results today. Revenues were $15 million, compared to $15.5 million in the prior-year period....
Vertex Pharmaceuticals Inc (NASDAQ: VRTX) Q2 2020 earnings call dated July 30, 2020 Corporate Participants: Michael Partridge — Senior Vice President, Investor...
Gilead Sciences Inc (NASDAQ: GILD) Q2 2020 earnings call dated July 30, 2020 Corporate Participants: Douglas Maffei — Senior Director, Investor Relations...
Gilead Sciences (NASDAQ: GILD) reported second-quarter financial results after the closing bell on Thursday. The biotechnology firm missed both the...
Amgen Inc (NASDAQ: AMGN) Q2 2020 earnings call dated July 28, 2020 Corporate Participants: Arvind Sood — Vice President of Investor Relations...
Biogen Inc. (NASDAQ: BIIB) Q2 2020 earnings call dated July 22, 2020 Corporate Participants: Joe Mara — Vice President of Finance and...
Novartis International AG (NYSE: NVS) Q2 2020 earnings call dated Jul. 21, 2020 Corporate Participants: Samir Shah — Global Head of Investor...
Biogen (NASDAQ: BIIB) reported a 12% increase in adjusted EPS and 2% growth in revenue for the second quarter of...
Moderna Inc (NASDAQ: MRNA) Moderna Vaccine Against COVID-19 Phase 1 Interim Results Publication Call dated July 15, 2020 Corporate Participants:...
A diverse population with varying infection rates will be among the biggest challenges during the phase 3 trials of its...
Avid Bioservices, Inc. (CDMO) Q4 2020 earnings call dated June 30, 2020 Corporate Participants: Tim Brons — Executive Vice President Rick Hancock — Interim...
Nektar Therapeutics (NKTR) Q1 2020 earnings call dated May 07, 2020 Corporate Participants: Jennifer Ruddock — Senior Vice President, Strategy and Corporate...
The patent war between Amarin (NASDAQ: AMRN) and the generic companies for cardiovascular drug Vascepa continues to be a headwind...
Affimed N.V. (AFMD) Q1 2020 earnings call dated Jun. 23, 2020 Corporate Participants: Alexander Fudukidis — Head of Investor Relations Adi Hoess — Chief...
